Enfusion Inc.

NYSE: ENFN · Real-Time Price · USD
10.76
-0.04 (-0.37%)
At close: Apr 17, 2025, 3:59 PM

Enfusion Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
201.61M 174.53M 150.35M 111.7M
Cost of Revenue
64.87M 57.64M 47.1M 31.84M
Gross Profit
136.74M 116.89M 103.25M 79.86M
Operating Income
6.16M 11.95M -11.96M -275.88M
Interest Income
1.69M n/a 413K n/a
Pretax Income
7.39M 11.48M -12.19M -281.66M
Net Income
2.82M 6.03M -13.26M -282.24M
Selling & General & Admin
103.86M 85.05M 98.05M 202.34M
Research & Development
26.73M 19.89M 17.16M 153.4M
Other Expenses
n/a n/a -638K -1.19M
Operating Expenses
130.58M 104.95M 115.21M 355.74M
Interest Expense
n/a n/a 413K 4.59M
Selling & Marketing Expenses
25.03M 20.42M 29.29M 51.73M
Cost & Expenses
195.46M 162.59M 162.31M 387.58M
Income Tax Expense
4.57M 2.23M 1.07M 579K
Shares Outstanding (Basic)
92.05M 88.2M 85.39M 65.58M
Shares Outstanding (Diluted)
129.55M 129.43M 132.65M 65.58M
EPS (Basic)
0.02 0.10 -0.16 -4.3
EPS (Diluted)
0.01 0.07 -0.1 -4.3
EBITDA
6.16M 21.93M -5.62M -271.91M
EBIT
6.16M 11.95M -11.96M -275.88M
Depreciation & Amortization
n/a 9.99M 6.6M 3.98M